Beam Therapeutics Inc.
BEAM
16.99
USD+0.32
(+1.92%)Day's range
16.33
17.52
52 wk Range
13.525
35.25
BEAM Income Statement
| Period Ending | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 18,000 | 24,000 | 51,844,000 | 60,920,000 | 377,709,000 | 63,518,000 | |
| Cost of Revenue | 11,000 | 650,000 | 5,407,000 | 103,179,000 | 16,441,000 | 22,577,000 | 437,381,000 | 0 | |
| Gross Profit | -11,000 | -650,000 | -5,389,000 | -103,155,000 | 35,403,000 | 38,343,000 | -59,672,000 | 41,593,000 | |
| Gross Profit Margin | — | — | -299.389 | -4,298.125 | 0.683 | 0.629 | -0.158 | 0.655 | |
| R&D Expenses | 5,859,000 | 33,873,000 | 54,619,000 | 103,179,000 | 387,087,000 | 311,594,000 | 437,381,000 | 367,561,000 | |
| General & Administrative Expenses | 2,021,000 | 11,868,000 | 20,553,000 | 29,605,000 | 57,222,000 | 87,805,000 | 116,813,000 | 111,525,000 | |
| Selling & Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| SG&A Expenses | 2,021,000 | 11,868,000 | 20,553,000 | 29,605,000 | 57,222,000 | 87,805,000 | 116,813,000 | 111,525,000 | |
| Other Expenses | 378,000 | -10,040,000 | -71,000 | 0 | 0 | 0 | 0 | 0 | |
| Total Operating Expenses | 7,880,000 | 45,741,000 | 75,172,000 | 132,784,000 | 444,309,000 | 399,399,000 | 554,194,000 | 479,086,000 | |
| Total Costs & Expenses | 7,880,000 | 45,741,000 | 75,172,000 | 132,784,000 | 444,309,000 | 399,399,000 | 554,194,000 | 479,086,000 | |
| Interest Income | 0 | 292,000 | 2,486,000 | 1,568,000 | 9,000 | 15,297,000 | 0 | 0 | |
| Interest Expense | 0 | 0 | 187,000 | 1,568,000 | 9,000 | 15,297,000 | 0 | 0 | |
| Depreciation & Amortization | 11,000 | 650,000 | 5,407,000 | 9,472,000 | 16,441,000 | 22,577,000 | 20,012,000 | 31,593,000 | |
| EBITDA | -7,991,000 | -45,091,000 | -71,651,000 | -128,025,000 | -392,465,000 | -324,332,000 | -156,473,000 | -383,975,000 | |
| EBITDA Margin | — | — | -3,980.611 | -5,334.375 | -7.57 | -5.324 | -0.414 | -6.045 | |
| Operating Income | -7,880,000 | -45,741,000 | -75,154,000 | -132,760,000 | -392,465,000 | -338,479,000 | -176,485,000 | -415,568,000 | |
| Operating Income Margin | — | — | -4,175.222 | -5,531.667 | -7.57 | -5.556 | -0.467 | -6.543 | |
| Total Other Income/Expenses (Net) | -122,000 | -70,997,000 | -3,172,000 | -61,832,000 | 21,827,000 | 78,301,000 | 45,324,000 | 38,865,000 | |
| Income Before Tax | -8,002,000 | -116,738,000 | -78,326,000 | -194,592,000 | -370,638,000 | -260,178,000 | -131,161,000 | -376,703,000 | |
| Pre-Tax Income Margin | — | — | -4,351.444 | -8,108 | -7.149 | -4.271 | -0.347 | -5.931 | |
| Income Tax Expense | 500,000 | -70,997,000 | 116,000 | 61,832,000 | -29,278,000 | 3,410,000 | 1,366,000 | 39,000 | |
| Net Income | -8,002,000 | -115,257,000 | -78,442,000 | -256,424,000 | -341,360,000 | -263,588,000 | -132,527,000 | -376,742,000 | |
| Net Income Margin | — | — | -4,357.889 | -10,684.333 | -6.584 | -4.327 | -0.351 | -5.931 | |
| Earnings Per Share (EPS) | -0.62 | -3.28 | -1.53 | -5.49 | -5.31 | -3.76 | -1.72 | -4.58 | |
| Diluted Earnings Per Share (EPS) | -0.62 | -3.28 | -1.53 | -5.49 | -5.31 | -3.76 | -1.72 | -4.58 | |
| Weighted Average Shares Outstanding | 12,952,944 | 35,137,576 | 51,339,708 | 46,733,221 | 64,227,676 | 70,015,305 | 77,151,771 | 82,313,008 | |
| Weighted Average Shares Outstanding (Diluted) | 12,952,944 | 35,137,576 | 51,339,708 | 46,733,221 | 64,227,676 | 70,015,305 | 77,151,771 | 82,313,008 |